Salona Global Medical Device Corporation (the
“
Company”) (TSXV:SGMD) today announced its
intention to change its name to “Evome Medical Technologies Inc.”
subject to governmental and regulatory approvals. The proposed name
change reflects the direction the new management team is taking
toward higher margin recovery science products and services to
advance organic growth and boost gross margins and reduce the focus
on lower margin contract manufacturing.
Management also affirmed it expects to report,
based on preliminary results, positive Adjusted EBITDA (defined
below) and net income for its third quarter ending September 30,
2023.
With the new name comes a more focused, higher
margin business plan. The plan is straight forward and solves the
biggest needs in the recovery science market: Next generation
solutions for physical therapy and chiropractic clinic customers
using (1) connectivity, (2) portability, and (3) artificial
intelligence (AI) to increase the amount of patients a physical
therapist can treat in a given hour - improving profitability,
patient care and therapist morale.
The solutions include both products, such as
Biodex and Mio-Guard currently in the Company’s portfolio, as well
as a new focus on services, all designed to improve the business
performance for physical therapy clinics, chiropractic businesses,
and athletic departments globally.
As part of the new business plan, the
Company:
(1) |
plans to eliminate its lower gross margin (15%-20%) contract
manufacturing services fully in the quarters to come and has
started notifying customers to find other contract manufacturing
suppliers to ensure smooth transition of their business; and |
(2) |
has promoted the Corporate Senior Controller of one of its
operating subsidiaries, Natalia Vakhitova, to Chief Financial
Officer. Ms. Vakhitova has over a decade of experience in
accounting and finance with cross border publicly listed
companies. |
The new management team plans to debut the new
line of next generation products and services in the coming weeks
culminating with a new investor website and presentation for
investor meetings targeted to launch November 16, 2023 in the U.S.
and Canada following its earnings report.
“Our new team made quick work on our turn-around
plan and based on preliminary results we anticipate generating a
profit for the quarter ending September 30, 2023 and expect
continued cross company efficiency improvements during the fourth
quarter of the year,” said CEO Mike Seckler. “Now that we have
stabilized the company and finished the integration of the
acquisitions made to date, we are urgently focused on revenue and
profit growth for 2024. We have quite a line-up of products and
services we will be rolling out to our physical therapy and
chiropractic clinic customers in 2024 that I believe will drive
revenue and profit growth. After studying this market for some
time, we have come to realize the next step in increasing
efficiency and profitability of our customers is delivering
products and services that are connected, portable and, where
possible, can use artificial intelligence to increase the ratio of
patients to physical therapists and chiropracters. I am looking
forward to the coming weeks as we reveal these exciting and
novel products to our customer base and our investors.”
Full financial results from the third quarter
ending September 30, 2023 will be filed with regulators on or
before November 14, 2023.
For more information please contact:
Mike SecklerChief Executive OfficerTel: 1 (800)
760-6826Email: Info@Salonaglobal.com
Non-GAAP Measures
This press release refers to "Adjusted EBITDA"
which is a non-GAAP and non-IFRS financial measure that does not
have a standardized meaning prescribed by GAAP or IFRS. The
Company’s presentation of this financial measure may not be
comparable to similarly titled measures used by other companies.
This non-GAAP financial measure assists the Company’s management in
comparing its operating performance over time because certain items
may obscure underlying business trends and make comparisons of
long-term performance difficult, as they are of a nature and/or
size that occur with inconsistent frequency or relate to discrete
acquisition plans that are fundamentally different from the ongoing
operating plans of the Company. The Company’s management also
believes that presenting this measure allows investors to view the
Company’s performance using the same measures that the Company uses
in evaluating its financial and business performance and
trends.
“Adjusted EBITDA” is defined as net loss
excluding interest expense, provision for income taxes,
depreciation of property and equipment, amortization of
right-of-use asset, amortization of intangible asset, foreign
exchange (loss) gain, other income, provision for impairment,
change in fair value of contingent consideration, transaction
costs, and stock-based compensation.
Preliminary Financial Metrics
This press release contains certain pre-released
third quarter financial metrics. The third quarter financial
metrics contained in this press release are preliminary and
represent the most current information available to the Company's
management, as financial closing procedures for the third quarter
ended September 30, 2023 are not yet complete. The Company's actual
consolidated audited financial statements for such period may
result in material changes to the financial metrics summarized in
this press release (including by any one financial metric, or all
of the financial metrics, being below or above the figures
indicated) as a result of the completion of normal quarter and year
end accounting procedures and adjustments, and also what one might
expect to be in the final consolidated financial statements based
on the financial metrics summarized in this press release. Although
the Company believes the expectations reflected in this press
release are based upon reasonable assumptions, the Company can give
no assurance that actual results will not differ materially from
these expectations.
Additional Information
Unless otherwise specified, all dollar amounts
in this press release are expressed in Canadian dollars.
Neither the TSXV nor its Regulation Services
Provider (as that term is defined in the policies of the TSXV)
accepts responsibility for the adequacy or accuracy of this
release.
Certain statements contained in this press
release constitute "forward-looking information" within the meaning
of the Private Securities Litigation Reform Act of 1995 and
applicable Canadian securities laws. These statements can be
identified by the use of forward-looking terminology such as
“expects” “believes”, “estimates”, "may", "would",
"could", "should",
"potential", "will", "seek", "intend", "plan", and
"anticipate", and similar expressions as they
relate to the Company, including: the proposed name
change; the Company’s new direction and its expectations of the
results of its new direction; the Company expecting to generate
positive Adjusted EBITDA and net income for its third quarter
ending September 30, 2023; the plan to debut a new line of next
generation products and services in the coming weeks culminating
with a new investor website and presentation for investor meetings
targeted to launch November 16, 2023 in the U.S. and Canada; and
the Company believing that the line-up of products and services it
intends to roll out to customers in 2024 will drive revenue and
profit growth.
All statements other
than statements of historical fact may be
forward-looking information. Such statements reflect
the Company's current views and intentions with respect to
future events, and current information available to the
Company, and are subject to certain risks, uncertainties and
assumptions, including: the Company receiving the necessary
approvals to change its name; the Company generating profits based
on cost cutting activities during Q3 2023, and adjusted pricing
already agreed to with certain contract manufacturing customers
being reflected in the financial statements for the third quarter
ending September 30, 2023. The Company cautions that the
forward-looking statements contained herein are qualified by
important factors that could cause actual results to differ
materially from those reflected by such statements. Such factors
include but are not limited to the general business
and economic conditions in the regions
in which the Company operates; the ability of the
Company to execute on
key priorities, including the successful
completion of acquisitions, business retention,
and strategic plans and to attract,
develop and retain key executives; difficulty
integrating newly acquired businesses; ongoing or new
disruptions in the supply chain, the extent and scope of such
supply chain disruptions, and the timing or extent of the
resolution or improvement of such disruptions; the ability
to implement business strategies and
pursue business opportunities; disruptions in
or attacks (including cyber-attacks) on
the Company’s information technology, internet,
network access or other voice or
data communications systems or services; the evolution
of various types of fraud or
other criminal behavior to
which the Company is exposed; the failure of third
parties to comply with their obligations to the
Company or its affiliates; the impact of
new and changes to, or application of, current laws and
regulations; granting of permits and licenses in a highly
regulated business; the overall
difficult litigation environment, including in the
United States; increased competition; changes in foreign currency
rates; increased funding costs
and market volatility due to market illiquidity and competition for
funding; the availability of funds and
resources to pursue operations; critical accounting
estimates and changes to accounting standards,
policies, and methods used by the Company; the
occurrence of natural and
unnatural catastrophic events and
claims resulting from such events; as well as those
risk factors discussed or referred to in the Company’s
disclosure documents filed with United States Securities and
Exchange Commission and available at www.sec.gov, and with the
securities regulatory authorities in certain provinces of Canada
and available at www.sedarplus.ca. Should any factor affect the
Company in an unexpected manner, or should assumptions underlying
the forward-looking information prove incorrect, the actual
results or events may differ materially from the results or
events predicted. Any such forward-looking information is
expressly qualified in its entirety by this cautionary
statement. Moreover, the Company does not assume responsibility
for the accuracy or completeness of such forward-looking
information. The forward-looking information included in this
press release is made as of the date of this press release and
the Company undertakes no obligation to publicly update or revise
any forward-looking information, other than as required by
applicable law.
Salona Global Medical De... (TSXV:SGMD)
Historical Stock Chart
From Dec 2024 to Jan 2025
Salona Global Medical De... (TSXV:SGMD)
Historical Stock Chart
From Jan 2024 to Jan 2025